DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Divis Labs Share Price Live Updates: Divis Labs Stock Performance Overview

Economic Times 2 hrs ago·30 Sept 2026, 3:30 am

Divis Laboratories is currently the most valuable company in India, with its market value recently surpassing the $100 billion mark. This makes it the first pharma firm in the country to achieve this milestone, driven by strong demand for its active pharmaceutical ingredients and global expansion. For investors, the stock's performance is a key indicator of the broader healthcare sector's health and the company's ability to compete in the international market.

The company's consistent growth and high valuation have attracted significant attention from both domestic and foreign investors. The stock's recent surge reflects confidence in its business model and long-term prospects. However, given its high valuation, investors should monitor upcoming quarterly earnings and any updates on new product launches or acquisitions to gauge future growth potential.